Online first
Clinical vignette
Published online: 2024-11-04
A case of a patient at reproductive age with BRCA2 and CHEK2 mutations and multiple uterine fibroids
1
, 1, 1, 1, 1
, 1, 1, 1, 1
DOI: 10.5603/gpl.95221
Pubmed: 39513237
Abstract
Not available
References
- Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022; 43(4): 678–719.
- Stewart EA, Laughlin-Tommaso SK, Catherino WH, et al. Uterine fibroids. Nat Rev Dis Primers. 2016; 2: 16043.
- Välimäki N, Kuisma H, Pasanen A, et al. Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability. Elife. 2018; 7.
- American College of Obstetricians and Gynecologists (ACOG). Encyclopedia of Global Health. 2008.
- Riggan KA, Stewart EA, Balls-Berry JE, et al. Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions. J Patient Exp. 2021; 8: 23743735211049655.
